Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease

Medical Science Monitor

Volumn 19, Issue , 2013, Pages 1063-1072

  Stepień, Mariusz ^a   Stepień, Anna ^a   Wlazeł, Rafał Nikodem ^a   Paradowski, Marek ^a   Banach, Maciej ^a   Rysz, Magdalena ^a   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Adipokines; Chronic kidney disease; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; RESISTIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY ADIPOSITY INDEX; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; VISCERAL ADIPOSITY INDEX; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT HEIGHT RATIO;

ADIPOKINES; ADIPOSITY; ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; BODY HEIGHT; CASE-CONTROL STUDIES; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RENAL INSUFFICIENCY, CHRONIC; STATISTICS, NONPARAMETRIC; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84888403655     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889390     Document Type: Article

References (45)

1. Chagnac A, Weinstein T, Korzets A et al: Glomerular hemodynamics in severe obesity. Am J Physiol/Renal Physiol, 2000; 278: F817-22.
2. Ejerblad E, Fored CM, Lindblad P et al: Obesity and risk for chronic renal failure. J Am Soc Nephrol, 2006; 17: 1695-702.
3. Peters AM, Ciapryna MB, Bowles FP, Glass DM: Obesity does not accelerate the decline in glomerular filtration rate associated with advancing age. Int J Obes, 2009; 33: 379-81.
4. Wickman Ch, Kramer H: Obesity and kidney disease: potential mechanisms. Semin Nephrol, 2013; 33: 14-22.
5. Chertow GM, Hsu Ch, Johansen KL: The enlarging body of evidence: obesity and chronic kidney disease. J Am Soc Nephrol, 2006; 17: 1501-2.
6. Eknoyan G: Obesity and chronic kidney disease. Nefrologia, 2011; 3: 397-403.
7. Griffin KA, Kramer H, Bidani AK: Adverse renal consequences of obesity. Am J Physiol/Renal Physiol, 2008; 294: F685-96.
8. Tesauro M, Mascali A, Franzese O et al: Chronic kidney disease, obesity and hypertension: the role of leptin and adiponectin. Int J Hypertens, 2012; 2012: 943605.
9. de Boer IH, Katz R, Fried LF et al: Obesity and change in estimated GFR among older adults. Am J Kidney Dis, 2009; 54: 1043-51.
10. Agarwal R, Bills JE, Light RP: Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the "obesity paradox'? Hypertension, 2010; 56: 893-900.
11. Naumnik B, Myśliwiec M: Renal consequences of obesity. Med Sci Monit, 2010; 16(8): RA163-70.
12. Whaley-Connell A, Pavey BS, Afroze A, Bakrins GL: Obesity and insulin resistance as risk factors for chronic kidney disease. JCMS, 2006; I: 209-14.
13. Axelsson J, Bergsten A, Qureshi AR et al: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int, 2006; 69: 596-604.
14. Lee CM, Huxley RR, Widma RP, Woodward M: Indices of abdominal obesity are better discrimination of cardiovascular risk factor than BMI: a meta-analysis. J Clin Epidem, 2008; 61(7): 646-53.
15. Gerchman F, Tong J, Utzschneider KM et al: Body mass index is associated with increased creatinine clearance by mechanism independent of body fat distribution. J Clin Endocrinol Metab, 2009; 94: 3781-88.
16. Noori N, Hosseinpanah F, Nasiri AA, Azizi F: Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr, 2009; 19: 228-37.
17. Elsayed EF, Sarnak MJ, Tighiouart H et al: Waist-to-hip ratio, body mass index and subsequent kidney disease and death. Am J Kidney Dis, 2008; 52: 29-38.
18. Burton JO, Gray LJ, Webb DR et al: Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population. Nephrol Dial Transplant, 2012; 27(5): 1860-66.
19. Amato MC, Giordano C, Galia M et al., for the AlkaMeSy Study Group: Visceral Adiposity Index. A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 2010; 33: 920-22.
20. Bergman RN, Stefanovski D, Buchanan TA et al: A better index of body adiposity. Obesity, 2011; 19(5): 1083-89.
21. Silva M, Vale B, Lemos C et al: Body adiposity index assess body fat with high accuracy in nondialyzed chronic kidney disease patients. Obesity (Silver Spring), 2013; 21(3): 546-52.
22. Kuan Y, Hossain M, Surman J et al: GFR prediction using the MDRD and Cockroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant, 2005; 20: 2394-401.
23. Lee JH, Chan JL, Yiannakouris N et al: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab, 2003; 88(10): 4848-56.
24. Prigent A: Monitoring renal function and limitations of renal function tests. Semin Nucl Med, 2008; 38: 32-46.
25. Verhave JC, Fesler P, Ribstein J et al: Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis, 2005; 46: 233-41.
26. Przybylowski P, Malyszko J, Malyszko J: Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft receipents. Med Sci Monit, 2010; 16(9): CR440-44.
27. Lokkegaaard N, Haupter L, Kristensen TB: Microalbuminuria in obesity Scand J Urol Nephrol, 1992; 26: 275-78.
28. Kawar B, Bello AK, El Nahas AM: High prevalence of microalbuminuria in the overweight and obese population: data from a UK Population Screening Programme. Nephron Clin Pract, 2009; 112: c205-12.
29. Ferris M, Hogan SL, Chin H et al: Obesity, albuminuria and urinalysis findings in US young adults from the Add Health Wave III Study. Clin J Am Soc Nephrol, 2007; 2: 1207-14.
30. Chang Y, Yoo T, Ryu S et al: Abdominal obesity, systolic blood pressure and microalbuminuria in normotensive and euglycemic Korean men. Int J Obes (Lond), 2006; 30: 800-4.
31. Thoenes M, Reil JC, Khan BV et al: Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Management, 2009; 5: 577-85.
32. D'Elia J, Roshan B, Maski M, Weinrauch LA: Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney. Int J Nephrol Renovasc Dis, 2009; 2: 39-49.
33. Yoon YS, Park HS, Yun KE, Kim SB: Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults. Metabolism Clin Exp, 2009; 58: 1737-42.
34. Shankar A, Syamala S, Xiao J, Muntner P: Relationship between plasma leptin level and chronic kidney disease. Int J Nephrol, 2012; 2012: 269532.
35. Papafragkaki DK, Tolis G: Obesity and renal disease: A possible role of leptin. Hormones, 2005; 4: 90-95.
36. Tang J, Yan H, Zhuang S: Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol, 2012; 2012: 608397.
37. Bełtowski J: Adiponectin and resistin-new hormones of whitw adipose tissue. Med Sci Monit, 2003; 9(2): RA55-61.
38. Mitsnefes M, Kartal J, Khoury P, Daniels S: Adiponectin in children with chronic kidney disease: role of adiposity and kidney dysfunction. Clin J Am Soc Nephrol, 2007; 2: 46-50.
39. Yano Y, Hoshide S, Ishikawa J et al: Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertens, 2007; 9: 775-82.
40. Ste{ogonek}pień M, Ste{ogonek}pień A, Wlazeł RN et al: Predictors of insulin resistance in patients with obesity: a pilot study. Angiology, 2012; [Epub ahead of print].
41. Stepień M, Rosniak-Bak K, Paradowski M et al: Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med Sci Monit, 2011; 17(11): PR13-18.
42. Ste{ogonek}pień M, Wlazeł RN, Paradowski M et al: Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo-and hypertensive patients-pilot study. Arch Med Sci, 2012; 8: 431-36.
43. Satirapoj B, Supasyndh O, Boonyavarakul A et al: The correlation of insulin resistance and renal function in non diabetic chronic kidney disease patients. J Med Assoc Thai, 2005; 88(Suppl. 3): S97-104.
44. Park JH, Oh SW, Ahn SY et al: Decreased estimated glomerular filtration rate is not directly related to increased insulin resistance. Diabetes Res Clin Pract, 2013; 99: 366-71.
45. Mohteshamzadeh M, Wong C, Whiticar R, Thomas S: Is there a link between insulin resistance and chronic kidney disease in men with treated hypertension? Analysis of 5-year data. Am J Nephrol, 2009; 29: 116-22.